Hyderabad: Hyderabad-based Biophore India Pharmaceuticals announced on Friday that it has applied for DCGI emergency use approval of Aviptadil Inhalation for marketing in India for the treatment of moderate to severe cases of Covid-19. Biophore has successfully developed Aviptadil and is backward integrated with in-house API (Active Pharmaceutical Ingredient). The company will be commencing commercial production […] The post Biophore Seeks DCGI Approval For Aviptadil For Covid Treatment appeared first on Ommcom News.
Hence then, the article about biophore seeks dcgi approval for aviptadil for covid treatment was published today ( ) and is available onOmmcom News ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.
Read More Details Finally We wish PressBee provided you with enough information of ( Biophore Seeks DCGI Approval For Aviptadil For Covid Treatment )